Volta, Laura https://orcid.org/0000-0003-2527-2451
Myburgh, Renier
Pellegrino, Christian https://orcid.org/0000-0001-7898-9988
Koch, Christian https://orcid.org/0009-0000-0681-4265
Maurer, Monique
Manfredi, Francesco
Hofstetter, Mara
Kaiser, Anne
Schneiter, Florin https://orcid.org/0000-0002-4242-4544
Müller, Jan
Buehler, Marco M. https://orcid.org/0000-0003-0850-3326
De Luca, Roberto https://orcid.org/0000-0001-7519-8689
Favalli, Nicholas
Magnani, Chiara F. https://orcid.org/0000-0003-2474-2159
Schroeder, Timm
Neri, Dario
Manz, Markus G. https://orcid.org/0000-0002-4676-7931
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_184747/1, 310030B_182003/1)
Krebsliga Schweiz (KFS-3846-02-2016)
Universität Zürich (Clinical Research Priority Program “ImmunoCure” of the University of Zurich, University Research Priority Project Translational Cancer Research, Clinical Research Priority Program “ImmunoCure”)
ETH Lymphoma Challenge Grant
Dr. Horst Böhlke Foundation
Deutsche Krebshilfe (Mildred Scheel-Postdoktorandenprogramm)
EC | Horizon 2020 Framework Programme (670603)
Article History
Received: 3 June 2024
Revised: 30 August 2024
Accepted: 4 September 2024
First Online: 18 September 2024
Competing interests
: The authors declare no competing interests.